+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tunneled Peripherally Inserted Central Catheters Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Tunneled Peripherally Inserted Central Catheters Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Tunneled Peripherally Inserted Central Catheters Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082000
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Section 1: Introduction to the Tunneled Peripherally Inserted Central Catheters Market

The peripherally inserted central catheter (PICC) segment has evolved significantly with the expansion of tunneled options optimized for long-term vascular access. Designed to combine the minimally invasive benefits of peripherally placed devices with the stable positioning of tunneled lines, these catheters have become critical to oncology, parenteral nutrition, and extended antibiotic therapies. As healthcare systems shift toward outpatient and home-based care, tunneled PICCs offer reduced infection risk, improved patient comfort, and cost efficiencies by minimizing hospital stays.

Recent advances in catheter materials, insertion techniques, and coatings have reinforced the role of tunneled PICCs in complex treatment regimens, while regulatory agencies worldwide continue strengthening guidelines to promote safety and efficacy. Moreover, growing awareness of catheter-related bloodstream infections has prompted providers to adopt tunneled PICCs as a best-practice standard for patients requiring months of vascular access.

Bridging acute care and home environments, these devices address critical gaps in continuity of care, supporting a more patient-centric model. This landscape demands a thorough understanding of drivers, challenges, and emerging innovations. Against this backdrop, this executive summary distills the most pressing trends, segmentation dynamics, regional nuances, and strategic imperatives to inform decision-making and shape the future of tunneled peripherally inserted central catheters.

Section 2: Transformative Shifts in the Tunneled PICC Landscape

Over the past several years, the landscape of tunneled peripherally inserted central catheters has undergone transformative shifts driven by technological breakthroughs, regulatory enhancements, and evolving care pathways. Novel antimicrobial coatings and biofilm-resistant materials have emerged to address infection challenges, while advanced imaging modalities such as ultrasound-guided bedside insertion have enhanced procedural accuracy and reduced complication rates. In parallel, catheter design has diversified to include single, double, and triple lumen options tailored to specific therapy regimens, providing clinicians with greater flexibility.

Regulatory authorities worldwide have intensified scrutiny on device safety, prompting manufacturers to invest in clinical validation and post-market surveillance. This emphasis on evidence-based innovation has accelerated the adoption of chlorhexidine-based and silver-coated antimicrobial alternatives alongside traditional antibiotic-impregnated products. At the same time, healthcare payers and institutions are incentivizing outpatient and home infusion models, increasing demand for reliable vascular access solutions that ensure patient autonomy and lower hospitalization costs.

Together, these forces are reshaping market dynamics, elevating providers’ expectations for performance, and fostering partnerships across clinical, technological, and supply chain stakeholders. As a result, industry participants must navigate a more complex environment characterized by heightened quality requirements, cost containment pressures, and patient-driven care models.

Section 3: Cumulative Impact of United States Tariffs 2025 on Supply Chains

The implementation of United States tariffs in 2025 has introduced a new layer of complexity to the supply chains underpinning tunneled PICC manufacturing and distribution. Increased duties on imported raw materials-particularly medical-grade polyurethane and silicone-have elevated production costs for manufacturers relying on global supply lines. In response, device developers are exploring local sourcing agreements and strategic partnerships to mitigate duty-related expenses and stabilize margins.

These tariff measures have also prompted some manufacturers to reassess their global footprint, shifting assembly operations closer to end markets to minimize cross-border fees. Meanwhile, distributors and healthcare providers are feeling the pressure of incremental price adjustments, necessitating more rigorous procurement strategies and cost-containment tactics. Negotiations around contract terms and volume commitments have become more prevalent as buyers seek to offset additional import costs.

Despite these headwinds, the overarching emphasis on infection prevention and long-term vascular access has sustained the adoption of tunneled PICCs. Manufacturers that proactively reformulate supply chains, diversify their vendor base, and demonstrate transparent pricing structures are better positioned to navigate the tariff-driven environment without compromising on quality or performance.

Section 4: Key Segmentation Insights Across Seven Dimensions

A granular analysis of the tunneled PICC market reveals nuanced insights across multiple dimensions of segmentation. By product type, the antimicrobial category commands significant attention through its subtypes: antibiotic-impregnated options that release targeted drugs, chlorhexidine-based coatings acclaimed for broad-spectrum efficacy, and silver-coated variants that leverage metal ion activity. In contrast, the non-antimicrobial cluster includes standard polyurethane devices prized for durability and transparent polyurethane models favored for site visualization.

Analyzing insertion procedures, bedside approaches are gaining momentum, particularly when guided by fluoroscopy or ultrasound, which streamline workflows and reduce turnaround times. Surgical insertions remain relevant for complex cases, with closed surgery techniques minimizing contamination risk and open surgery ensuring direct visualization in anatomically challenging patients.

Patient demographics shape product selection as well: middle-aged and young adults often require high-flow infusions and thus benefit from double or triple lumen designs, while elderly adults demand devices that accommodate delicate vasculature. Pediatric segments - encompassing children, infants, and neonates - prioritize low-profile catheters that balance safety with flexibility.

Material choice between polyurethane and silicone influences device flexibility, thrombogenicity, and biocompatibility, driving clinicians to align selections with therapy duration and patient sensitivity. End-user environments further stratify demand, as ambulatory surgical centers focus on quick-turn procedures, outpatient and private clinics emphasize patient throughput, home nursing and self-administration segments seek ease-of-use, and hospitals-both acute care and specialty-require robust performance under varied care protocols. Finally, design type and catheter length converge to address clinical complexity: single lumen devices for routine infusions, double and triple lumens for simultaneous therapies, short-length catheters for peripheral access, and long-length catheters for deep vascular placement.

Section 5: Key Regional Insights Informing Market Dynamics

Regional dynamics play a pivotal role in shaping adoption patterns and competitive strategies. In the Americas, robust healthcare infrastructure and reimbursement frameworks support widespread integration of tunneled PICCs in oncology and parenteral nutrition programs, while domestic manufacturers drive innovation in antimicrobial coatings. Europe, Middle East & Africa exhibit heterogeneity driven by diverse regulatory environments and procurement models; Western Europe prioritizes rigorous clinical validation, the Middle East invests in capacity building for home healthcare, and Africa pursues partnerships to enhance supply chain resilience. Across Asia-Pacific, rapid healthcare modernization in markets such as China and India fuels demand for cost-effective catheter solutions, while Japan and Australia lead in adopting advanced insertion techniques and high-performance materials. Transitioning from regional disparities toward global standardization, market participants must optimize distribution networks, tailor engagement strategies to local stakeholders, and ensure regulatory alignment to capitalize on each geography’s unique growth levers.

Section 6: Key Company Strategies and Competitive Positioning

Leading manufacturers are reinforcing their market positions through targeted product launches, strategic collaborations, and facility expansions. AngioDynamics, Inc. and Avanos Medical, Inc. have accelerated innovation in antimicrobial and ultrasound-compatible devices, while B. Braun Melsungen AG and Becton, Dickinson and Company leverage extensive clinical trial data to validate new catheter materials. Boston Scientific Corporation and C. R. Bard, Inc. prioritize partnerships with academic centers to refine insertion protocols, and Cardinal Health and Cook Medical focus on supply chain diversification and customer training initiatives.

Fresenius Medical Care AG & Co. KGaA and ICU Medical, Inc. integrate connector technologies to enhance safety, and Medical Components, Inc. (MedComp) advances custom catheter configurations to meet niche clinical requirements. Medtronic plc and Nipro Corporation drive cost-optimized manufacturing processes, whereas Smiths Medical and Teleflex Incorporated invest in design enhancements that facilitate bedside insertion. Teleflex Medical OEM and Terumo Corporation emphasize cross-platform compatibility, and the Vygon Group expands its regional footprint through joint ventures. Collectively, these players are shaping a competitive landscape characterized by rapid technology adoption, intensified clinical validation, and strategic market entry tactics.

Section 7: Actionable Recommendations for Industry Leaders

To sustain competitive advantage and address evolving clinical needs, industry leaders should pursue a multi-pronged strategy. First, accelerating the development of next-generation antimicrobial and biofilm-resistant materials will align product portfolios with stringent infection prevention mandates. Second, investing in digital integration-such as catheter tip tracking systems and telehealth-enabled monitoring-can enhance procedural efficacy and patient engagement. Third, diversifying supply chains through regional manufacturing hubs and dual-sourcing frameworks will mitigate tariff exposure and logistical disruptions.

Additionally, forging strategic collaborations with infusion therapy providers, oncology networks, and home healthcare agencies will expand usage pathways and elevate market visibility. Engaging with regulatory bodies early in the development cycle can streamline approvals and position organizations as preferred partners. Finally, tailoring market access strategies to high-growth regional segments, such as outpatient infusion centers in the Asia-Pacific region and home administration channels in the Americas, will unlock new revenue streams and reinforce long-term resilience.

Section 8: Conclusion and Strategic Outlook

The tunneled peripherally inserted central catheter segment stands at the intersection of innovation, regulation, and shifting care models. Technological advancements in antimicrobial coatings and imaging-guided insertion have elevated safety standards, while tariff pressures and regional variations underscore the need for agile supply chain design and localized market strategies. Deep segmentation analysis has illuminated opportunities to customize product offerings by patient demographics, procedure types, material preferences, and care settings. Meanwhile, competitive intelligence highlights that success hinges on continuous product innovation, clinical evidence generation, and collaborative partnerships across the value chain. As healthcare systems worldwide embrace outpatient and home-based care, industry participants must balance cost, performance, and patient experience to secure leadership positions in this dynamic market.

Market Segmentation & Coverage

This research report categorizes the Tunneled Peripherally Inserted Central Catheters Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Antimicrobial
    • Antibiotic-Impregnated
    • Chlorhexidine-Based
    • Silver-Coated
  • Non-Antimicrobial
    • Standard Polyurethane
    • Transparent Polyurethane
  • Bedside Insertion
    • Fluoroscopy-Guided
    • Ultrasound-Guided
  • Surgical Insertion
    • Closed Surgery
    • Open Surgery
  • Adult Patients
    • Middle Aged Adults
    • Young Adults
  • Geriatric Patients
    • Elderly Adults
  • Pediatric Patients
    • Children
    • Infants
    • Neonates
  • Polyurethane
  • Silicone
  • Ambulatory Surgical Centers
  • Clinics
    • Outpatient Clinics
    • Private Clinics
  • Home Healthcare
    • Home Nursing
    • Self Administration
  • Hospitals
    • Acute Care Hospitals
    • Specialty Hospitals
  • Double Lumen
  • Single Lumen
  • Triple Lumen
  • Long-Length Catheters
  • Short-Length Catheters

This research report categorizes the Tunneled Peripherally Inserted Central Catheters Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Tunneled Peripherally Inserted Central Catheters Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AngioDynamics, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health
  • Cook Medical
  • Fresenius Medical Care AG & Co. KGaA
  • ICU Medical, Inc.
  • Medical Components, Inc. (MedComp)
  • Medtronic plc
  • Nipro Corporation
  • Smiths Medical
  • Teleflex Incorporated
  • Teleflex Medical OEM
  • Terumo Corporation
  • Vygon Group

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tunneled Peripherally Inserted Central Catheters Market, by Product Type
8.1. Introduction
8.2. Antimicrobial
8.2.1. Antibiotic-Impregnated
8.2.2. Chlorhexidine-Based
8.2.3. Silver-Coated
8.3. Non-Antimicrobial
8.3.1. Standard Polyurethane
8.3.2. Transparent Polyurethane
9. Tunneled Peripherally Inserted Central Catheters Market, by Insertions Procedures
9.1. Introduction
9.2. Bedside Insertion
9.2.1. Fluoroscopy-Guided
9.2.2. Ultrasound-Guided
9.3. Surgical Insertion
9.3.1. Closed Surgery
9.3.2. Open Surgery
10. Tunneled Peripherally Inserted Central Catheters Market, by Patient Demographics
10.1. Introduction
10.2. Adult Patients
10.2.1. Middle Aged Adults
10.2.2. Young Adults
10.3. Geriatric Patients
10.3.1. Elderly Adults
10.4. Pediatric Patients
10.4.1. Children
10.4.2. Infants
10.4.3. Neonates
11. Tunneled Peripherally Inserted Central Catheters Market, by Material Type
11.1. Introduction
11.2. Polyurethane
11.3. Silicone
12. Tunneled Peripherally Inserted Central Catheters Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.3.1. Outpatient Clinics
12.3.2. Private Clinics
12.4. Home Healthcare
12.4.1. Home Nursing
12.4.2. Self Administration
12.5. Hospitals
12.5.1. Acute Care Hospitals
12.5.2. Specialty Hospitals
13. Tunneled Peripherally Inserted Central Catheters Market, by Design Type
13.1. Introduction
13.2. Double Lumen
13.3. Single Lumen
13.4. Triple Lumen
14. Tunneled Peripherally Inserted Central Catheters Market, by Catheter Length
14.1. Introduction
14.2. Long-Length Catheters
14.3. Short-Length Catheters
15. Americas Tunneled Peripherally Inserted Central Catheters Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Tunneled Peripherally Inserted Central Catheters Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Tunneled Peripherally Inserted Central Catheters Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AngioDynamics, Inc.
18.3.2. Avanos Medical, Inc.
18.3.3. B. Braun Melsungen AG
18.3.4. Becton, Dickinson and Company
18.3.5. Boston Scientific Corporation
18.3.6. C. R. Bard, Inc.
18.3.7. Cardinal Health
18.3.8. Cook Medical
18.3.9. Fresenius Medical Care AG & Co. KGaA
18.3.10. ICU Medical, Inc.
18.3.11. Medical Components, Inc. (MedComp)
18.3.12. Medtronic plc
18.3.13. Nipro Corporation
18.3.14. Smiths Medical
18.3.15. Teleflex Incorporated
18.3.16. Teleflex Medical OEM
18.3.17. Terumo Corporation
18.3.18. Vygon Group
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET MULTI-CURRENCY
FIGURE 2. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET MULTI-LANGUAGE
FIGURE 3. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2024 VS 2030 (%)
FIGURE 20. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIBIOTIC-IMPREGNATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CHLORHEXIDINE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SILVER-COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY STANDARD POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY TRANSPARENT POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY FLUOROSCOPY-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLOSED SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MIDDLE AGED ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ELDERLY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME NURSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ACUTE CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY LONG-LENGTH CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SHORT-LENGTH CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 114. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 116. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 118. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 119. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 120. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 121. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 122. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 123. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 124. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 128. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 130. CANADA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 201. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 203. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 204. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 205. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 206. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 207. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 208. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 209. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 210. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 211. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 214. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 215. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 217. CHINA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 218. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 220. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 221. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 222. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 223. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 224. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 225. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 226. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 227. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 228. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 229. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 232. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY DESIGN TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY CATHETER LENGTH, 2018-2030 (USD MILLION)
TABLE 252. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 254. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY NON-ANTIMICROBIAL, 2018-2030 (USD MILLION)
TABLE 255. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY INSERTIONS PROCEDURES, 2018-2030 (USD MILLION)
TABLE 256. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY BEDSIDE INSERTION, 2018-2030 (USD MILLION)
TABLE 257. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY SURGICAL INSERTION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN TUNNELED PERIPHERALLY INSERTED CENTRAL CATHETE

Companies Mentioned

  • AngioDynamics, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health
  • Cook Medical
  • Fresenius Medical Care AG & Co. KGaA
  • ICU Medical, Inc.
  • Medical Components, Inc. (MedComp)
  • Medtronic plc
  • Nipro Corporation
  • Smiths Medical
  • Teleflex Incorporated
  • Teleflex Medical OEM
  • Terumo Corporation
  • Vygon Group

Methodology

Loading
LOADING...

Related Topics

Related Reports

U.S. Vascular Access Devices Market Size, Share & Trends Analysis Report By Product (Central Venous Catheters (CVC), Peripherally Inserted Central Catheter (PICCs)), And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Vascular Access Devices Market Size, Share & Trends Analysis Report By Product (Central Venous Catheters (CVC), Peripherally Inserted Central Catheter (PICCs)), And Segment Forecasts, 2025 - 2030

  • Report
  • 105 Pages
  • United States
From
Vascular Access Systems Market - Forecasts from 2025 to 2030 - Product Image

Vascular Access Systems Market - Forecasts from 2025 to 2030

  • Report
  • 149 Pages
  • Global
From
Tunneled Central Venous Catheter Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Tunneled Central Venous Catheter Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global, United States Global, United States
From
Central Venous Catheters Market Report 2025 - Product Image

Central Venous Catheters Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Vascular Access Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vascular Access Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.